Bedel Financial Consulting Inc. Cuts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bedel Financial Consulting Inc. lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,252 shares of the medical equipment provider’s stock after selling 192 shares during the period. Bedel Financial Consulting Inc.’s holdings in Intuitive Surgical were worth $1,697,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently modified their holdings of ISRG. Massachusetts Financial Services Co. MA bought a new stake in Intuitive Surgical in the 3rd quarter worth approximately $558,807,000. Proficio Capital Partners LLC grew its holdings in shares of Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after purchasing an additional 948,902 shares in the last quarter. FMR LLC increased its position in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Wilmington Savings Fund Society FSB raised its stake in Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after purchasing an additional 552,058 shares in the last quarter. Finally, Strategic Financial Concepts LLC raised its position in Intuitive Surgical by 50,740.8% during the fourth quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider’s stock valued at $163,202,000 after purchasing an additional 312,056 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 12,598 shares of company stock valued at $7,223,467 over the last ninety days. 0.90% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of brokerages recently issued reports on ISRG. Truist Financial raised their price target on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Citigroup lifted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Leerink Partners upped their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Royal Bank of Canada raised their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Finally, Jefferies Financial Group upped their target price on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. One analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $566.98 on Tuesday. The firm has a 50-day simple moving average of $570.66 and a 200-day simple moving average of $530.08. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The firm has a market cap of $201.95 billion, a P/E ratio of 88.45, a P/E/G ratio of 5.85 and a beta of 1.39.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.